Project Details
Projekt Print View

Comparison of Liposomal Bupivacaine, Plain Bupivacaine, and Placebo for Transversus Abdominis Plane Blocks: A Randomized, Blinded Trial

Subject Area Anaesthesiology
Gynaecology and Obstetrics
Term from 2022 to 2025
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 498537330
 
Final Report Year 2025

Final Report Abstract

Enhanced Recovery After Surgery (ERAS) pathways are designed to improve patient recovery by minimizing opioid use and related side effects. One method involves transversus abdominis plane (TAP) blocks, which deliver local anesthetics to nerves in the abdominal wall . While TAP blocks are commonly used, their effectiveness is debated, particularly in managing visceral pain or extending pain relief. Liposomal bupivacaine, a long-acting anesthetic, is often included in TAP blocks to prolong their duration, but its efficacy remains uncertain. This study investigated whether TAP blocks using liposomal bupivacaine reduce opioid use after major abdominal surgery compared to plain bupivacaine or placebo. The primary focus was on opioid consumption during the first 48 hours post-surgery. Secondary outcomes included time to sensation return, pain scores, and opioid use from 48–72 hours. 261 patients undergoing major abdominal surgery were randomly assigned to receive one of three treatments: 1) Liposomal bupivacaine, 2) Plain bupivacaine, 3) Placebo (normal saline). All groups had access to intravenous opioids for additional pain relief. Opioid use during the first 24 hours averaged 26 mg, 33 mg, and 31 mg (median values) for liposomal bupivacaine, plain bupivacaine, and placebo, respectively. Differences between groups were not statistically significant. Opioid consumption between 24–48 hours and secondary outcomes, including pain scores, sensation return, and opioid use from 48–72 hours, were also similar across groups. These findings suggest that TAP blocks, regardless of whether liposomal bupivacaine is used, may not significantly reduce opioid use or improve pain management after abdominal surgery. Clinicians may need to reconsider the routine use of TAP blocks and explore alternative pain management strategies. For patients, this highlights the importance of discussing individualized recovery plans with healthcare providers.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung